Dr. Muralidharan Jagadeesan, MD

Dr. Jagadeesan practices at The George Washington University Hospital in Washington, District of Columbia, part of Universal Health Services.

Dr. Jagadeesan's NPI, 1073623302, was assigned on August 30, 2006. Dr. Jagadeesan holds Georgia license 044495.

Dr. Jagadeesan's primary practice is The George Washington University Hospital, at 900 23rd St NW, Washington, DC 20037 in The District County. The practice phone is (202) 716-4605.

Dr. Jagadeesan's primary practice is The George Washington University Hospital in Washington, District of Columbia, part of Universal Health Services. The medical group on file is The GW Medical Faculty Associates.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Jagadeesan practices. Vendor and product names are available with a free account.

Nephrology is Dr. Jagadeesan's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Jagadeesan is board certified in nephrology by the American Board of Internal Medicine. Dr. Jagadeesan is licensed in Georgia.

CMS data shows 433 Medicare services from Dr. Jagadeesan across 4 procedure codes in 2024, for 131 Medicare patients. Medicare paid $40,491 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 131 Medicare patients who saw Dr. Jagadeesan in 2024. The largest group is under 65, with 84 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 55% are also on Medicaid. Their average risk score is 4.95, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Jagadeesan's median patient age at 59, with 39% women.

In 2024, Dr. Jagadeesan wrote 807 Medicare Part D claims for 99 patients. 85% of them were for generic drugs. CMS names the drug for 570 of them, across 22 drugs with 11 or more claims each, at $55,528 in total drug cost. In 2023, CMS named 787 claims across 28 drugs.

Dr. Jagadeesan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Jagadeesan as offering telehealth.

CMS Open Payments shows 58 general payments to Dr. Jagadeesan from 15 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 76% of the total. Veloxis Pharmaceuticals, Inc. paid the most, $7,183.